Circulating levels of selected adipokines in women with gestational diabetes and type 2 diabetes
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F20%3A73601499" target="_blank" >RIV/61989592:15110/20:73601499 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00098892:_____/20:N0000055
Výsledek na webu
<a href="https://jab.zsf.jcu.cz/pdfs/jab/2020/02/04.pdf" target="_blank" >https://jab.zsf.jcu.cz/pdfs/jab/2020/02/04.pdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.32725/jab.2020.007" target="_blank" >10.32725/jab.2020.007</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Circulating levels of selected adipokines in women with gestational diabetes and type 2 diabetes
Popis výsledku v původním jazyce
Backgrounds: Adiponectin, adipocyte-fatty acid binding protein (A-FABP), and Wnt1 inducible signaling pathway protein-1 (WISP-1) are adipokines closely associated with insulin resistance. The aim of the study was to compare their levels in women with gestational diabetes (GDM), type 2 diabetes mellitus (T2DM) and healthy controls and determine their relation to metabolic parameters. Methods: Women with GDM, T2DM and healthy women were included in this cross-sectional study. In addition to adipokines, anthropometric, lipid parameters, markers of insulin resistance and glucose control were assessed in all participants. Results: Compared to healthy controls (n = 35) significantly lower levels of adiponectin were detected in women with GDM (n = 50), whereas in women with T2DM (n = 50) higher levels of A-FABP and WISP-1 and lower levels of adiponectin were found. Women with T2DM had also lower levels of adiponectin and higher levels of A-FABP compared to women with GDM. A-FABP and diponectin were independently associated with levels of triglycerides, HDL-cholesterol and C-peptide insulin resistance index. WISP-1 correlated only with waist circumference. Conclusions: Adverse adipokines production reflecting dysfunctional fat tissue is less presented in women with GDM than in women with T2DM, but more expressed compared to healthy women.
Název v anglickém jazyce
Circulating levels of selected adipokines in women with gestational diabetes and type 2 diabetes
Popis výsledku anglicky
Backgrounds: Adiponectin, adipocyte-fatty acid binding protein (A-FABP), and Wnt1 inducible signaling pathway protein-1 (WISP-1) are adipokines closely associated with insulin resistance. The aim of the study was to compare their levels in women with gestational diabetes (GDM), type 2 diabetes mellitus (T2DM) and healthy controls and determine their relation to metabolic parameters. Methods: Women with GDM, T2DM and healthy women were included in this cross-sectional study. In addition to adipokines, anthropometric, lipid parameters, markers of insulin resistance and glucose control were assessed in all participants. Results: Compared to healthy controls (n = 35) significantly lower levels of adiponectin were detected in women with GDM (n = 50), whereas in women with T2DM (n = 50) higher levels of A-FABP and WISP-1 and lower levels of adiponectin were found. Women with T2DM had also lower levels of adiponectin and higher levels of A-FABP compared to women with GDM. A-FABP and diponectin were independently associated with levels of triglycerides, HDL-cholesterol and C-peptide insulin resistance index. WISP-1 correlated only with waist circumference. Conclusions: Adverse adipokines production reflecting dysfunctional fat tissue is less presented in women with GDM than in women with T2DM, but more expressed compared to healthy women.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30202 - Endocrinology and metabolism (including diabetes, hormones)
Návaznosti výsledku
Projekt
<a href="/cs/project/NV18-01-00139" target="_blank" >NV18-01-00139: Gestační diabetes mellitus - podíl hormonů entero-insulární osy, vybraných adipokinů a střevní mikroflóry na vznik jeho různých fenotypů</a><br>
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2020
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Journal of Applied Biomedicine
ISSN
1214-021X
e-ISSN
—
Svazek periodika
18
Číslo periodika v rámci svazku
2-3
Stát vydavatele periodika
CZ - Česká republika
Počet stran výsledku
7
Strana od-do
54-60
Kód UT WoS článku
000563565100004
EID výsledku v databázi Scopus
2-s2.0-85090097561